Metastatic disease to the breast: the Washington University experience

Table 1 Characteristics of patients with metastatic disease to the breast

Primary malignancy	Age at Diagnosis (years)*	Time to metastasis (months)**	Vital Status	Secondary Survival (months)***	Breast Laterality	Breast Surgical Treatment
Melanoma	26	48	Dead	5	Left	Excision
Melanoma	23	276	Dead	6	Right	Biopsy only
Melanoma	59	34	Dead	9	Left	Biopsy only
Melanoma	83	9	Dead	24	Right	Mastectomy
Melanoma	70	36	Dead	36	Right	Excision, ALND
Melanoma	38	66	Dead	38	Left	MRM
Thyroid	13	264	Dead	16	Left	Excision
Thyroid	17	144	Alive with disease	18	Left	Biopsy only
Thyroid	29	14	Alive with disease	120	Bilateral	Excision
Ovarian	59	84	Dead	6	Right	Excisional biopsy
Ovarian	63	14	Alive with disease	14	Right	MRM
Ovarian	49	3	Dead	37	Right	Excisional biopsy
Lung (small cell)	83	0	Alive with disease	21	Right	Biopsy only
Lung (neuroendocrine)	30	38	Alive with disease	7	Left	Excision
Lung (neuroendocrine)	35	0	Alive with disease	9	Bilateral	Biopsy only
Lung (neuroendocrine)	28	8	Dead	17	Right	Excision
Tongue	48	10	Dead	8	Right	Biopsy only
Kidney	67	48	Dead	12	Left	Biopsy only

ALND = axillary lymph node dissection; MRM = modified radical mastectomy
*Age at diagnosis of primary malignancy
** Time between primary malignancy diagnosis and the development of a breast metastasis
***Survival after the diagnosis of a breast metastasis until death or study follow-up.

ISSN: 1477-7819